Some studies reported that rare SORL1 PTC variants are associated with a fivefold increased risk for early-onset AD, suggesting a comparable risk effect for AD as for carriers of one APOE ε4 allele [107]. The gene discussed is APOE; the disease is Alzheimer disease.